Skip to content

Vivani Medical VANI Return on equity

Return on equity at other companies

Eli Lilly logo
Eli LillyLLY
107.6%+29.9pp
Amgen logo
AmgenAMGN
101.3%-4.4pp
Altimmune logo
AltimmuneALT
-42.7%-8.7pp
Viking Therapeutics logo
Viking TherapeuticsVKTX
-70%-94.5pp
Wave Life Sciences logo
Wave Life SciencesWVE
-53.7%
Prime Medicine logo
Prime MedicinePRME
-216.1%+1,519pp

Other financials

Income statement

See full
Revenue-
Gross profit$130.0K
Operating income-$6.8M-4.0%
Net income-$6.8M-7.6%
EPS (diluted)-$0.08+27.3%

Balance sheet

See full
Cash & equivalents$19.0M+57.7%
Total debt$18.3M-3.5%
Total equity$19.1M+64.2%
Total assets$42.4M+19.5%

Cash flow

See full
Operating cash flow-$6.2M-20.0%
CapEx$3.0K-40.0%
Free cash flow-$6.2M-19.9%

Valuation

See full
Market cap$106.93M+37.8%
Enterprise value$106.17M+17.4%

Profitability

See full
Gross margin36.3%
Operating margin-1,004.9%
Net margin-994.1%
FCF margin-832.3%

Returns & leverage

See full
Debt / equity-0.7×
Current ratio3.2×+0.8×

Where this comes from

Calculated from Vivani Medical’s reported figures.

Based on trailing twelve months.

The official record: Vivani Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vivani Medical's return on equity?
Vivani Medical (VANI) reported return on equity of -176.4% in Q1 2026.
How has Vivani Medical's return on equity changed year-over-year?
Vivani Medical's return on equity decreased by 49.8% year-over-year, from -117.8% to -176.4%.
What is the long-term trend for Vivani Medical's return on equity?
Over 5 years (2020 to 2025), Vivani Medical's return on equity has grown at a -13.1% compound annual growth rate (CAGR), from -322.6% to -159.6%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.